神经元形可能存在于阿尔茨海默氏症患者的大脑中
1Department of Anesthesiology, University of Virginia, Charlottesville, VA 22908, USA.
Cells
|October 15, 2025
概括
在哺乳动物大脑中可能会发生以ACE2积累为标志的细胞死亡形式 - - 脊髓炎. 这一过程可能与衰老和阿尔茨海默病有关,为治疗提供了新的点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 脊髓炎是一种新型细胞死亡途径,在多虫肠道细胞中被发现.
- ангиотензин转化酶2 (ACE2) 的积累意味着勃起细胞.
- 脑细胞损失是阿尔茨海默病 (AD) 的一个标志.
研究的目的:
- 为了调查哺乳动物大脑中勃起病的存在.
- 为了确定勃起症是否与衰老和阿尔茨海默氏症的神经病理学有关.
主要方法:
- 在老年小鼠,AD模型小鼠和人类AD患者的海马体中评估了ACE2染色.
- 检查了ACE2-阳性细胞中的细胞形态,NeuN和TUNEL染色.
- 研究了-对神经元中ACE2表达的作用.
主要成果:
- 在老年小鼠,AD模型小鼠和人类AD患者的海马体中观察到ACE2染色的增加.
- 阳性ACE2细胞表现出细胞损伤/死亡的迹象,包括碎片化的细胞核和TUNEL阳性.
- 在AD模型中的ACE2阳性神经元通常对酸阳性,从而诱导ACE2表达.
结论:
- 脊髓炎可能发生在哺乳动物的大脑中,特别是神经元中.
- 衰老和阿尔茨海默氏症的神经病理似乎增加了勃起.
- 向勃起症是一个潜在的治疗策略,用于大脑衰老和AD.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Disorders of the Nervous Tissue
2.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.5K
Role of Neurotransmitters in Memory
2.5K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.5K


